ArticleMicrosystems & nanoengineering2026
Microfluidic-optical integrated portable platform with handheld pump for wash-free plasmonic detection of thrombin and SARS-CoV-2 spike protein.
Article in Microsystems & nanoengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Point-of-care testing (POCT) requires rapid, quantitative results without the complexity of laboratory instrumentation. Conventional assays like ELISA and PCR are often limited by long processing times, multiple washing procedures, and a dependence on bulky, external power-consuming pumps. To address these challenges, we developed a fully integrated, palm-sized platform validated with two high-impact biomarkers: thrombin, a critical regulator of blood coagulation for cardiovascular and renal diagnostics, and the SARS-CoV-2 spike protein, a primary antigen for rapid viral screening. The platform's innovation lies in its user-independent, electricity-free fluidic operation, featuring a manual suction pump with a compression spring that ensures high reproducibility (CV < 4.5%). Additionally, a serpentine microchannel design was incorporated to promote Dean flow-induced inertial mixing, accelerating aggregation kinetics for a true wash-free plasmonic assay. Our system provides real-time quantitative detection within 5 min, achieving sub-nanomolar limits of detection (LoD: 0.5 nM for thrombin and 0.4 nM for spike protein). Wireless connectivity allows for immediate data visualization on smartphones. By bridging the gap between sophisticated laboratory analysis and portable, manual operation, this platform offers a robust and scalable solution for decentralized clinical diagnostics.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.